NCT01484119 - Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis | Biotech Hunter

Enrollment

630

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

ACT-129968

daily tablets

DRUG

Placebo

matching placebo tablets and capsules

DRUG

Cetirizine

daily capsules

Trial Locations (7)

Clinical Investigative Site 7907, Kerrville

Clinical Investigative Site 7903, New Braunfels

Clinical Investigative Site 7901, San Antonio

Clinical Investigative Site 7902, San Antonio

Clinical Investigative Site 7904, San Antonio

Clinical Investigative Site 7906, San Antonio

Clinical Investigative Site 7905, Austin